{"id":5902,"date":"2025-05-29T14:19:30","date_gmt":"2025-05-29T14:19:30","guid":{"rendered":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/?page_id=5902"},"modified":"2025-12-20T18:05:04","modified_gmt":"2025-12-20T18:05:04","slug":"biologics","status":"publish","type":"page","link":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/","title":{"rendered":"Biologics"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Biologics<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

Pipeline<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Our top priority is to ensure patient safety and therapeutic efficacy in the development of veterinary mesenchymal stem cell (MSC) based biologics.<\/p>

Our current pipeline includes advanced development programs designed for canine and equine patients. Two of our products are intended for dogs \u2014 one addresses osteoarthritis (OA), while the other is designed to treat atopic dermatitis (AD). A third product targets joint inflammation in horses. In addition, we are conducting research and development on a second atopic dermatitis therapy for dogs, this time using secretome \u2014 a mixture of proteins and signaling molecules secreted by stem cells into the extracellular environment.<\/p>

Our lead product, BCX-CM-J, for the treatment of canine osteoarthritis, is expected to become the world\u2019s first veterinary medicinal product containing allogeneic canine stem cells. A centralized registration procedure is currently ongoing with the European Medicines Agency (EMA).<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
Product<\/td>BCX-CM-J<\/td>BCX-EM<\/td>BCX-CM-AD<\/td><\/tr><\/thead>
Species<\/td>\"\"<\/td>\"\"<\/td>\"\"<\/td><\/tr>
Condition<\/td>OA<\/td>OA<\/td>AD<\/td><\/tr>
Route of
adminitration<\/td>		i.a.<\/td>i.a.<\/td>i.v.<\/td><\/tr>
Target Animal\u2028Safety<\/td>\"\"<\/td>\"\"<\/td>\"\"<\/td><\/tr>
Pivotal study<\/td>\"\"<\/td>\"\"<\/td>\"\"<\/td><\/tr>
Application to EMA<\/td>\"\"<\/td>\"\"<\/td>Second indication for BCX-CM-J<\/td><\/tr>
List of questions\u2028from EMA<\/td>\"\"<\/td>\"\"<\/td>\u00a0<\/td><\/tr><\/tbody><\/table>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

BCX-CM-J<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tAn allogeneic stem cell-based medicinal product for the treatment of osteoarthritis in dogs.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tLearn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>
\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

BCX-CM-AD<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tAn allogeneic stem cell-based medicinal product for the treatment of atopic dermatitis in dogs.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tLearn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>
\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

BCX-EM<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tAn allogeneic stem cell-based medicinal product developed for the treatment of osteoarthritis in horses.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tLearn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div>
\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t

BCX-CM-Sec<\/h3>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\tA research project aimed at developing a cell-free biological drug effective in treating atopic dermatitis in dogs.\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t<\/path><\/svg>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\tLearn more<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<\/div><\/div><\/div>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Biologics Pipeline Our top priority is to ensure patient safety and therapeutic efficacy in the development of veterinary mesenchymal stem cell (MSC) based biologics. Our current pipeline includes advanced development programs designed for canine and equine patients. Two of our products are intended for dogs \u2014 one addresses osteoarthritis (OA), while the other is designed […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-5902","page","type-page","status-publish","hentry"],"yoast_head":"\nBiologics - Bioceltix<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Biologics - Bioceltix\" \/>\n<meta property=\"og:description\" content=\"Biologics Pipeline Our top priority is to ensure patient safety and therapeutic efficacy in the development of veterinary mesenchymal stem cell (MSC) based biologics. Our current pipeline includes advanced development programs designed for canine and equine patients. Two of our products are intended for dogs \u2014 one addresses osteoarthritis (OA), while the other is designed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/\" \/>\n<meta property=\"og:site_name\" content=\"Bioceltix\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-20T18:05:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/\",\"url\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/\",\"name\":\"Biologics - Bioceltix\",\"isPartOf\":{\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#website\"},\"datePublished\":\"2025-05-29T14:19:30+00:00\",\"dateModified\":\"2025-12-20T18:05:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Strona g\u0142\u00f3wna\",\"item\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Biologics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#website\",\"url\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/\",\"name\":\"Bioceltix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#organization\",\"name\":\"Bioceltix\",\"url\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png\",\"contentUrl\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png\",\"width\":274,\"height\":73,\"caption\":\"Bioceltix\"},\"image\":{\"@id\":\"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Biologics - Bioceltix","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Biologics - Bioceltix","og_description":"Biologics Pipeline Our top priority is to ensure patient safety and therapeutic efficacy in the development of veterinary mesenchymal stem cell (MSC) based biologics. Our current pipeline includes advanced development programs designed for canine and equine patients. Two of our products are intended for dogs \u2014 one addresses osteoarthritis (OA), while the other is designed […]","og_url":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/","og_site_name":"Bioceltix","article_modified_time":"2025-12-20T18:05:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/","url":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/","name":"Biologics - Bioceltix","isPartOf":{"@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#website"},"datePublished":"2025-05-29T14:19:30+00:00","dateModified":"2025-12-20T18:05:04+00:00","breadcrumb":{"@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/biologics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Strona g\u0142\u00f3wna","item":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/"},{"@type":"ListItem","position":2,"name":"Biologics"}]},{"@type":"WebSite","@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#website","url":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/","name":"Bioceltix","description":"","publisher":{"@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#organization","name":"Bioceltix","url":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#\/schema\/logo\/image\/","url":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","contentUrl":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/wp-content\/uploads\/2025\/05\/logo-bioceltix.png","width":274,"height":73,"caption":"Bioceltix"},"image":{"@id":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/pages\/5902","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/comments?post=5902"}],"version-history":[{"count":27,"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/pages\/5902\/revisions"}],"predecessor-version":[{"id":7668,"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/pages\/5902\/revisions\/7668"}],"wp:attachment":[{"href":"https:\/\/nervous-vaughan.46-242-130-154.plesk.page\/en\/wp-json\/wp\/v2\/media?parent=5902"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}